Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Metz

Showing results (121-130 of 258) with videos related to

Pageof 26
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2012
Mast cells orchestrate type 2 immunity to helminths through regulation of tissue-derived cytokinesMatthew R Hepworth, Emilia Daniłowicz-Luebert, Sebastian Rausch, et al.
Journal of the American Academy of Dermatology|April 17, 2021
Sleep disturbance in adult dermatologic patients: A cross-sectional study on prevalence, burden, and associated factorsMax Spindler, Katarzyna Przybyłowicz, Marlena Hawro, et al.
Experimental Dermatology|October 1, 2014
Polidocanol inhibits cowhage - but not histamine-induced itch in humansTomasz Hawro, Joachim W Fluhr, Valérie Mengeaud, et al.
The Journal of Investigative Dermatology|May 22, 2014
Substance P is upregulated in the serum of patients with chronic spontaneous urticariaMartin Metz, Clemens Krull, Tomasz Hawro, et al.
The Journal of Allergy and Clinical Immunology|August 3, 2010
Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumabMarkus Magerl, Petra Staubach, Sabine Altrichter, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 5, 2006
Skin mast cells control T cell-dependent host defense in Leishmania major infectionsMarcus Maurer, Susanna Lopez Kostka, Frank Siebenhaar, et al.
Frontiers in Immunology|August 5, 2022
STAT3 gain-of-function is not responsible for low total IgE levels in patients with autoimmune chronic spontaneous urticariaMerle Sauer, Jörg Scheffel, Stefan Frischbutter, et al.
The World Allergy Organization Journal|March 18, 2020
Management of urticarial vasculitis: A worldwide physician perspectivePavel Kolkhir, Hanna Bonnekoh, Emek Kocatürk, et al.
The Journal of Allergy and Clinical Immunology|June 6, 2022
Autoimmune chronic spontaneous urticariaPavel Kolkhir, Melba Muñoz, Riccardo Asero, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 27, 2023
Anti-IL-23 treatment with tildrakizumab can be effective in omalizumab-refractory chronic spontaneous urticaria: A case seriesHanna Bonnekoh, Lea Kiefer, Thomas Buttgereit, et al.
Pageof 26

Showing results (121-130 of 258) with videos related to

Sort By:
Pageof 26
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2012
Mast cells orchestrate type 2 immunity to helminths through regulation of tissue-derived cytokinesMatthew R Hepworth, Emilia Daniłowicz-Luebert, Sebastian Rausch, et al.
Journal of the American Academy of Dermatology|April 17, 2021
Sleep disturbance in adult dermatologic patients: A cross-sectional study on prevalence, burden, and associated factorsMax Spindler, Katarzyna Przybyłowicz, Marlena Hawro, et al.
Experimental Dermatology|October 1, 2014
Polidocanol inhibits cowhage - but not histamine-induced itch in humansTomasz Hawro, Joachim W Fluhr, Valérie Mengeaud, et al.
The Journal of Investigative Dermatology|May 22, 2014
Substance P is upregulated in the serum of patients with chronic spontaneous urticariaMartin Metz, Clemens Krull, Tomasz Hawro, et al.
The Journal of Allergy and Clinical Immunology|August 3, 2010
Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumabMarkus Magerl, Petra Staubach, Sabine Altrichter, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 5, 2006
Skin mast cells control T cell-dependent host defense in Leishmania major infectionsMarcus Maurer, Susanna Lopez Kostka, Frank Siebenhaar, et al.
Frontiers in Immunology|August 5, 2022
STAT3 gain-of-function is not responsible for low total IgE levels in patients with autoimmune chronic spontaneous urticariaMerle Sauer, Jörg Scheffel, Stefan Frischbutter, et al.
The World Allergy Organization Journal|March 18, 2020
Management of urticarial vasculitis: A worldwide physician perspectivePavel Kolkhir, Hanna Bonnekoh, Emek Kocatürk, et al.
The Journal of Allergy and Clinical Immunology|June 6, 2022
Autoimmune chronic spontaneous urticariaPavel Kolkhir, Melba Muñoz, Riccardo Asero, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 27, 2023
Anti-IL-23 treatment with tildrakizumab can be effective in omalizumab-refractory chronic spontaneous urticaria: A case seriesHanna Bonnekoh, Lea Kiefer, Thomas Buttgereit, et al.
Pageof 26